Xu H - Search Results

1

Neuroprotective treatment with the nitrone compound OKN-007 mitigates age-related muscle weakness in aging mice.

Xu H, Piekarz KM, Brown JL, Bhaskaran S, Smith N, Towner RA, Van Remmen H. Xu H, et al. Geroscience. 2024 Oct;46(5):4263-4273. doi: 10.1007/s11357-024-01134-y. Epub 2024 Mar 21. Geroscience. 2024. PMID: 38512579 Free PMC article.

2

Elevated phospholipid hydroperoxide glutathione peroxidase (GPX4) expression modulates oxylipin formation and inhibits age-related skeletal muscle atrophy and weakness.

Czyżowska A, Brown J, Xu H, Sataranatarajan K, Kinter M, Tyrell VJ, O'Donnell VB, Van Remmen H. Czyżowska A, et al. Among authors: xu h. Redox Biol. 2023 Aug;64:102761. doi: 10.1016/j.redox.2023.102761. Epub 2023 Jun 1. Redox Biol. 2023. PMID: 37279604 Free PMC article.

3

Reactive oxygen species in the pathogenesis of sarcopenia.

Xu H, Brown JL, Bhaskaran S, Van Remmen H. Xu H, et al. Free Radic Biol Med. 2025 Feb 1;227:446-458. doi: 10.1016/j.freeradbiomed.2024.11.046. Epub 2024 Nov 28. Free Radic Biol Med. 2025. PMID: 39613046 Free article. Review.

4

AI is a viable alternative to high throughput screening: a 318-target study.

Atomwise AIMS Program. Atomwise AIMS Program. Sci Rep. 2024 Apr 2;14(1):7526. doi: 10.1038/s41598-024-54655-z. Sci Rep. 2024. PMID: 38565852 Free PMC article.

5

Author Correction: AI is a viable alternative to high throughput screening: a 318-target study.

Atomwise AIMS Program. Atomwise AIMS Program. Sci Rep. 2024 Sep 16;14(1):21579. doi: 10.1038/s41598-024-70321-w. Sci Rep. 2024. PMID: 39284864 Free PMC article. No abstract available.

6

The Interaction Between Vasculogenic Mimicry and the Immune System: Mechanistic Insights and Dual Exploration in Cancer Therapy.

Liu S, Kang M, Ren Y, Zhang Y, Ba Y, Deng J, Luo P, Cheng Q, Xu H, Weng S, Zuo A, Han X, Liu Z, Pan T, Gao L. Liu S, et al. Among authors: xu h. Cell Prolif. 2025 Jan 26:e13814. doi: 10.1111/cpr.13814. Online ahead of print. Cell Prolif. 2025. PMID: 39865437 Review.

7

Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling.

Shao W, Xu H, Zeng K, Ye M, Pei R, Wang K. Shao W, et al. Among authors: xu h. Stem Cell Res Ther. 2025 Jan 26;16(1):27. doi: 10.1186/s13287-025-04139-2. Stem Cell Res Ther. 2025. PMID: 39865320 Review.

8

A cross-sectional study on the association between physical activity and the risk of colon cancer based on NHANES 2007-2018.

Zou D, Xin X, Xu Y, Xu H, Xu T. Zou D, et al. Among authors: xu h. Sci Rep. 2025 Jan 26;15(1):3297. doi: 10.1038/s41598-025-88067-4. Sci Rep. 2025. PMID: 39865142

9

Efficient Discovery of Robust Prognostic Biomarkers and Signatures in Solid Tumors.

Liu Z, Deng J, Xu H, Liu L, Zhang Y, Ba Y, Zhang Z, He F, Xie L. Liu Z, et al. Among authors: xu h. Cancer Lett. 2025 Jan 24:217502. doi: 10.1016/j.canlet.2025.217502. Online ahead of print. Cancer Lett. 2025. PMID: 39864538

10

Nucleoside antiviral agents with atypical structures and new targets.

Xu H, Li B, Tang K, Yang J, Zhan P. Xu H, et al. Bioorg Med Chem Lett. 2025 Jan 24:130110. doi: 10.1016/j.bmcl.2025.130110. Online ahead of print. Bioorg Med Chem Lett. 2025. PMID: 39864529 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,896 results

Search Page

Filters